Nadine Bley

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Nucleic acids research

Cancer research

RNA biology

eLife

This page only lists publications with an associated author ORCID identifier.

Publications

Alice Wedler, Nadine Bley, Markus Glaß, Simon Müller, Alexander Rausch, Marcell Lederer, Julia Urbainski, Laura Schian, Kingsley-Benjamin Obika, Theresa Simon, Lara Meret Peters, Claudia Misiak, Tommy Fuchs, Marcel Köhn, Roland Jacob, Tony Gutschner, Christian Ihling, Andrea Sinz, Stefan Hüttelmaier
RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing. Nucleic acids research 52 (7) (2024)
Alice Wedler, Nadine Bley, Markus Glaß, Simon Müller, Alexander Rausch, Marcell Lederer, Julia Urbainski, Laura Schian, Kingsley-Benjamin Obika, Theresa Simon, Lara Meret Peters, Claudia Misiak, Tommy Fuchs, Marcel Köhn, Roland Jacob, Tony Gutschner, Christian Ihling, Andrea Sinz, Stefan Hüttelmaier
RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing. Nucleic acids research (2024)
Alice Wedler, Nadine Bley, Markus Glaß, Simon Müller, Alexander Rausch, Marcell Lederer, Julia Urbainski, Laura Schian, Kingsley-Benjamin Obika, Theresa Simon, Lara Meret Peters, Claudia Misiak, Tommy Fuchs, Marcel Köhn, Roland Jacob, Tony Gutschner, Christian Ihling, Andrea Sinz, Stefan Hüttelmaier
RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing. Nucleic acids research 52 (7) (2024)
Alice Wedler, Nadine Bley, Markus Glaß, Simon Müller, Alexander Rausch, Marcell Lederer, Julia Urbainski, Laura Schian, Kingsley-Benjamin Obika, Theresa Simon, Lara Meret Peters, Claudia Misiak, Tommy Fuchs, Marcel Köhn, Roland Jacob, Tony Gutschner, Christian Ihling, Andrea Sinz, Stefan Hüttelmaier
RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing. Nucleic acids research 52 (7) (2024)
Alice Wedler, Nadine Bley, Markus Glaß, Simon Müller, Alexander Rausch, Marcell Lederer, Julia Urbainski, Laura Schian, Kingsley-Benjamin Obika, Theresa Simon, Lara Meret Peters, Claudia Misiak, Tommy Fuchs, Marcel Köhn, Roland Jacob, Tony Gutschner, Christian Ihling, Andrea Sinz, Stefan Hüttelmaier
RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing. Nucleic acids research 52 (7) (2024)
Till Braun, Johanna Stachelscheid, Nadine Bley, Sebastian Oberbeck, Moritz Otte, Tony Andreas Müller, Linus Wahnschaffe, Markus Glaß, Katharina Ommer, Marek Franitza, Birgit Sybille Gathof, Janine Altmüller, Michael Hallek, Daniel Auguin, Stefan Hüttelmaier, Alexandra Schrader, Marco Herling
Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia. Cancer research 82 (9) (2022)
Neus Mestre-Farràs, Santiago Guerrero, Nadine Bley, Ezequiel Rivero, Olga Coll, Eva Borràs, Eduard Sabidó, Alberto Indacochea, Carlos Casillas-Serra, Aino I Järvelin, Baldomero Oliva Miguel, Alfredo Castello, Stefan Hüttelmaier, Fátima Gebauer
Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis. Nucleic acids research 50 (14) (2022)
Johanna Stachelscheid, Qu Jiang, Christoph Markus Aszyk, Kathrin Warner, Nadine Bley, Tony A Müller, Olga Vydzhak, Konstantinos Symeonidis, Giuliano Crispatzu, Petra Mayer, Stuart James Blakemore, Gudrun Goehring, Sebastian Newrzela, Stephanie Hippler, Sandra Robrecht, Karl-Anton Kreuzer, Christian P Pallasch, Marcus Krueger, Axel Lechner, Kirsten Fischer, Stephan Stilgenbauer, Dirk Beutner, Michael Hallek, Daniel Auguin, Stefan Hüttelmaier, Johannes Bloehdorn, Elena Vasyutina, Marco Herling
The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL. Blood (2022)
Nadine Bley, Annekatrin Schott, Simon Müller, Danny Misiak, Marcell Lederer, Tommy Fuchs, Chris Aßmann, Markus Glaß, Christian Ihling, Andrea Sinz, Nikolaos Pazaitis, Claudia Wickenhauser, Martina Vetter, Olga Ungurs, Hans-Georg Strauss, Christoph Thomssen, Stefan Hüttelmaier
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer. RNA biology 18 (3) (2020)
Nadine Bley
Finding the mutations that drive resistance. eLife 9 (2020)

Nadine Bley.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nadine Bley